Articles From: Asbury Automotive Group Announces Cash Tender Offer and Consent Solicitation to GE Healthcare Announces Omnyx™ Digital Pathology Collaboration with Caradigm

Sign-up for Osmium Partners' Four Point Action Plan For Rosetta Stone investment picks
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the results of a data-driven analysis conducted in collaboration with TransCelerate BioPharma Inc. ("TransCelerate"), which assesses the value of source document verification (SDV) in a risk-based approach to clinical trial site monitoring.
Sign-up for Medidata and TransCelerate BioPharma Inc. Announce Findings of Joint Research Initiative on Clinical Trial Site Monitoring Methods investment picks
SC’14 – Mellanox® Technologies, Ltd.
Sign-up for Mellanox Introduces Programmable Network Adapter Product Line with Application Acceleration Engine investment picks
CIT Group Inc. (NYSE:CIT) , a global leader in transportation finance, today announced that CIT Maritime Finance provided a $24.1 million senior secured credit facility to Blue Wall Shipping Limited, an investment holding company.
Sign-up for CIT Provides $24.1 Million Financing to Blue Wall Shipping Limited investment picks
Content Security and Secure Cloud Storage Portfolio Available to ArrowSphere Solution Providers CAMPBELL, Calif.
Sign-up for Barracuda Solutions Now Available in the ArrowSphere Cloud Marketplace investment picks EL SEGUNDO, CA --
Sign-up for Named to "2014 Best Places to Work in Los Angeles" List investment picks
Imperva , Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced scheduled participation at the following upcoming investor conferences: A live webcast, as well as the replay, of these presentations will be accessible from the investors page of Imperva’s website at .
Sign-up for Imperva to Present at Upcoming Investor Conferences investment picks GEORGE TOWN, GRAND CAYMAN, CAYMAN ISLANDS --
Sign-up for Consolidated Water Co. Ltd. to Present at LD MICRO "Main Event" Investor Conference on Tuesday, December 2, 2014 investment picks LENEXA, KS --
Sign-up for Digital Ally to Present at LD MICRO "Main Event" Micro-Cap Growth Conference on Wednesday, December 3, 2014 investment picks
IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospital medicine and post-acute physician group practice company, announced today that Claire de Marcellus Paris, M.D., and Olevia Pitts, M.D., SFHM were named by ACP Hospitalist , a publication of the American College of Physicians, as two of the Top Ten Hospitalists in the nation.
Sign-up for Two Physicians from IPC The Hospitalist Company Named Top Hospitalists of 2014 investment picks
Electro Scientific Industries, Inc. (Nasdaq: ESIO), the premier source for innovative laser-based manufacturing solutions for the microtechnology industry, today announced that its board of directors declared a quarterly cash dividend of $0.08 per share.
Sign-up for ESI Declares Quarterly Dividend investment picks
Oplink Communications (OPLK) has agreed to be acquired by privately-held Koch Industries for about $445 million in cash.
Sign-up for Oplink to be bought by Koch Industries for 14% premium investment picks
Millennials Are the Most Likely to Shop on Those Dates NEW YORK , Nov.
Sign-up for Most Americans Won't Shop on Either Black Friday or Cyber Monday investment picks
- All six trials met primary efficacy endpoint - - Data presented at AHA Scientific Sessions 2014 - PARIS AND TARRYTOWN, N.Y. , Nov.
Sign-up for Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol investment picks
Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) today announced updated interim results from its ongoing ARMOR2 Phase 2 clinical trial of galeterone in castration-resistant prostate cancer (CRPC) patients.
Sign-up for Tokai Pharmaceuticals Presents Updated Interim Galeterone ARMOR2 Data Showing Activity in Patients with Castration-Resistant Prostate Cancer (CRPC) Including Those Showing a Variant Form of Prostate Cancer Resistant to Hormone Therapy investment picks
SCHAFFHAUSEN, Switzerland , Nov.
Sign-up for TE Connectivity Opens Wearables Lab to Address Rapid Growth in Market investment picks
Sign-up for Destination Maternity Declares Quarterly Cash Dividend investment picks
BlackBerry's stock (BBRY) slumped 4.7% in premarket trade Wednesday, after Morgan Stanley analyst James Faucette downgraded the smartphone maker because he believes the market has become too optimistic about the company's ability to meet software sales targets.
Sign-up for BlackBerry's stock slumps after Morgan Stanley downgrade investment picks
Sierra Club Receives $500 Donation for Each Residential SunPower Solar System Installed Through the Program SAN JOSE, Calif.
Sign-up for Ford and SunPower Welcome Sierra Club as Newest Partner of National Drive Green for Life Program investment picks OMAHA, NE --
Sign-up for Solutionary Named a Leader in Managed Security Services by Independent Research Firm investment picks
Sign-up for Criteo to Present at the NASDAQ OMX 31st Investor Program investment picks
Kofax® Limited (NASDAQ: KFX)(LSE: KFX), a leading provider of smart process applications for the business critical First Mile™ of customer interactions, today reported it was issued three new patents by the United States Patent and Trademark Office (USPTO). The Company now has 54 issued patents and 60 pending applications, with 47 percent of the total relating to mobile imaging technologies.
Sign-up for Kofax Receives Three New Patents for Advanced Mobile Technology investment picks
- Statistically significant and robust reductions in key biomarkers of ventricular remodeling and inflammation following single, two-hour infusion - New data consistent with previously announced improvements in left ventricular systolic function and suppression of biomarkers highly correlated with poor clinical outcomes SAN DIEGO , Nov.
Sign-up for New Data From Nonclinical Heart Failure Study To Be Presented At American Heart Association Conference investment picks
GE Healthcare, a leader in technology innovation, today announced it will resell Caradigm’s Single Sign-On and Context Management solutions in the United States, Canada, and specific EU countries to provide connectivity between the Omnyx™ digital pathology platforms and designated Anatomic Pathology Laboratory Information Systems (APLIS). When pathologists diagnose cancers, they evaluate tissue in the context of a patient’s history, order more tests on the tissue if necessary, and deliver their findings to an oncologist*. The oncologist then uses the pathologist’s report to determine the course of treatment.
Sign-up for GE Healthcare Announces Omnyx™ Digital Pathology Collaboration with Caradigm investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.


Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Asbury Automotive Group Announces Cash Tender Offer and Consent Solicitation to GE Healthcare Announces Omnyx™ Digital Pathology Collaboration with Caradigm
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent